|
26-mag-2021 |
To meet the high demand for lipids, a key component of mRNA-based vaccines and therapeutics, Merck has launched a new, high-purity synthetic cholesterol product, nine months ahead of schedule.
|
20210526 |
|
|
20-mag-2021 |
Merck introduced a new solution improving productivity in the lab through a more flexible and streamlined nucleic acid purification process — GenElute™-E Single Spin purification kits.
|
20210520 |
|
|
18-mag-2021 |
Merck today announced that VectorY has been selected as the European winner of its 2021 Advance Biotech Grant Program.
|
20210518 |
|
|
04-mag-2021 |
Merck today announced a partnership with Topco Scientific Co. (TSC), a leading semiconductor supplier in Taiwan, to increase the use of more sustainable materials for the electronics industry.
|
20210504 |
|
|
31-mar-2021 |
Merck today announced a strategic partnership with the Faculty of Mathematics and Natural Sciences, Universitas Indonesia (FMIPA-UI) to establish the first Collaboration Laboratory between the company and the university to advance life science research and innovation development in Indonesia.
|
20210331 |
|
|
17-mar-2021 |
Merck will add a single-use assembly production unit at its Life Science Center in Molsheim, France.
|
20210317 |
|
|
16-mar-2021 |
As part of its ongoing commitment to renewable energy, Merck has signed a 12-year, off-site, virtual power purchase agreement with Enel Green Power for the construction of a future wind and storage project in Texas.
|
20210316 |
|
|
25-feb-2021 |
Merck today announced an agreement with Alteogen, Inc., of South Korea, providing late-stage CDMO services through Merck BioReliance® End-to-End Solutions.
|
20210225 |
|
|
15-feb-2021 |
Merck today launched an enhanced Design for Sustainability (DfS) framework, a unique approach to holistically integrate sustainability into Life Science products, systems and services.
|
20210215 |
|
|
04-feb-2021 |
Merck today announced seven expanded partnerships with leading nonprofit organizations across the world.
|
20210204 |
|
|
07-gen-2021 |
Merck today announced the acquisition of AmpTec, a leading Hamburg, Germany-based, mRNA contract development and manufacturing organization (CDMO).
|
20210107 |
|
|
07-dic-2020 |
Merck today announced the broadening of its manufacturing footprint with a combined € 40 million investment at its production facilities in Danvers, Massachusetts, and Jaffrey, New Hampshire, USA.
|
20201207 |
|
|
20-nov-2020 |
Merck KGaA, Darmstadt, Germany, today announced that its Massachusetts-based businesses, MilliporeSigma, EMD Serono and EMD Performance Materials, have again been named to The Boston Globe’s annual “Top Places to Work 2020” list.
|
20201120 |
|
|
07-nov-2020 |
Merck and Transcenta, a global biotherapeutics company, have announced a strategic technology collaboration to implement continuous manufacturing for protein therapeutics.
|
20201107 |
|
|
06-nov-2020 |
Merck today announced the signing of a Letter of Intent with Donghao Lansheng (Group) Co., Ltd.
|
20201106 |
|
|
10-nov-2020 |
Merck today announced that its first-to-market Blazar™ platform from the BioReliance® portfolio has won R&D 100 and CPhI Awards for its ability to reduce testing times by up to 80 percent.
|
20201110 |
|
|
29-ott-2020 |
Merck today announced a collaboration with Mammoth Biosciences Inc., of South San Francisco, California, for the development, scale-up and commercial production of Mammoth’s CRISPR-based SARS CoV-2 diagnostic test.
|
20201029 |
|
|
19-ott-2020 |
Merck today announced that Combined Therapeutics Inc., Cambridge, Massachusetts, USA, has been selected as the North American winner of its 2020 Advance Biotech Grant Program.
|
20201019 |
|
|
13-ott-2020 |
Merck has bolstered its viral vector manufacturing capabilities with the launch of its VirusExpress™ Lentiviral Production Platform.
|
20201013 |
|
|
12-ott-2020 |
Merck today announced that it has signed agreements licensing its CRISPR technology to two companies — PanCELLa, a cell therapy firm based in Toronto, Canada and Takara Bio USA, Inc., a biotechnology company based in Mountain View, California, USA.
|
20201012 |
|
|
08-ott-2020 |
Merck today celebrated the topping-out ceremony for its new membrane production plant in Darmstadt, Germany.
|
20201008 |
|
|
08-ott-2020 |
Merck Merck, a leading science and technology company, is collaborating with D1Med, a Shanghai-based biopharmaceutical start-up precision-medical company, to accelerate production of D1Med’s 3D cell culture technology applications used in the drug discovery process.
|
20201008 |
|
|
06-ott-2020 |
MilliporeSigma today inaugurated a new $14.4 million industrial water treatment plant at its Jaffrey, New Hampshire, location.
|
20201006 |
|
|
15-set-2020 |
Merck today announced an expansion of its Singapore biosafety testing laboratory services.
|
20200915 |
|
|
09-set-2020 |
Merck today announced a € 59 million expansion of its HPAPI and ADC manufacturing capabilities and capacity at its facility near Madison, Wisconsin, USA.
|
20200909 |
|
|
03-set-2020 |
Merck today announced the donation of research instruments and materials worth IDR 1.2 billion (€ 74,000) to support the efforts of Eijkman Institute for Molecular Biology, Indonesia, in its efforts to accelerate vaccine development research. The institute is developing a Covid-19 vaccine based on a local virus strain, in collaboration with several local research institutions.
|
20200903 |
|
|
30-lug-2020 |
Merck today announced that it won a Top Project of the Year award from Environment + Energy Leader for its DOZN™ system, a quantitative tool that evaluates the relative greenness of chemicals and chemical processes against the 12 Principles of Green Chemistry.
|
20200730 |
|
|
15-lug-2020 |
Merck has announced plans to build a new, € 18 million laboratory facility in Buchs, Switzerland to support the company’s rapidly growing reference materials business.
|
20200715 |
|
|
10-lug-2020 |
Merck opened its M Lab™ Collaboration Center in Shanghai, the company’s largest of nine centers worldwide.
|
20200710 |
|
|
06-lug-2020 |
Merck today announced that VAR2 Pharmaceuticals has been selected as the European winner of its 2020 Advance Biotech Grant Program.
|
20200706 |
|
|
01-lug-2020 |
A new report details potential paths to solutions to overcoming the global Covid-19 crisis and ways to prepare for or even prevent a future pandemic.
|
20200701 |
|
|
01-lug-2020 |
Merck today enhanced its advanced bioprocess portfolio through the acquisition of RESOLUTION Spectra Systems.
|
20200701 |
|
|
10-giu-2020 |
Merck and 10x Genomics, Inc., a single cell and spatial genomics technologies company, today announced that they have developed a powerful new option for biological experiments.
|
20200610 |
|
|
27-mag-2020 |
Merck and Baylor College of Medicine, Houston, Texas, USA, today announced an extension of their ongoing collaboration to advance a manufacturing platform to fight Covid-19.
|
20200527 |
|
|
11-mag-2020 |
Merck today announced that two of its CRISPR-Cas9-assisted genome-editing patents have been allowed in the United States.
|
20200511 |
|
|
30-apr-2020 |
Merck today unveiled the next component of its BioContinuum™ Platform, the Bio4C™ Software Suite, creating a first-of-its-kind ecosystem that combines process control, analytics and plant-level automation.
|
20200430 |
|
|
21-apr-2020 |
Merck today announced a second Carlsbad, California, U.S.A.-based facility for its BioReliance® viral and gene therapy service offering.
|
20200421 |
|
|
14-apr-2020 |
Merck and The Jenner Institute today announced that the Jenner Institute has laid the foundation for large-scale production of its Covid-19 vaccine candidate, ChAdOx1 nCoV-19.
|
20200414 |
|
|
07-apr-2020 |
Merck today announced that the United States Patent and Trademark Office has granted the company’s patent for CRISPR-chrom technology.
|
20200407 |
|
|
03-mar-2020 |
Merck today launched its LANEXO™ Lab Inventory, Safety and Compliance Management System, a new digital laboratory informatics solution designed to drastically reduce time in labs and improve data quality and traceability.
|
20200303 |
|
|
18-feb-2020 |
Merck today announced that it has been selected by Swedish molecular diagnostics firm Elypta as the contract manufacturer for Elypta’s clinical diagnostic liquid biopsy kits.
|
20200218 |
|
|
11-feb-2020 |
Merck today introduced its BrightLab™ cloud-based inventory management and instrument connectivity platform for research scientists.
|
20200211 |
|
|
10-gen-2020 |
Merck today announced the opening of new, non-profit center where Indian students and researchers can learn the latest genome-editing and single-molecule biomolecule biomarker detection technologies.
|
20200110 |
|
|
19-dic-2019 |
Merck today announced that it has signed a license agreement providing Promega Corp.
|
20191219 |
|
|
26-nov-2019 |
Merck today announced that the Japan Patent Office and the Intellectual Property Office of Singapore have each allowed the company’s patent application for the use of paired CRISPR nickases.
|
20191126 |
|
|
18-nov-2019 |
Merck today announced it has received a prestigious R&D 100 Award for its Eshmuno® CP-FT Resin, a first-to-market product used in biopharmaceutical manufacturing.
|
20191118 |
|
|
18-nov-2019 |
Merck today announced the completion of a £9 million expansion to its Gillingham distribution centre.
|
20191118 |
|
|
12-nov-2019 |
Merck today announced that it has signed a license agreement providing Evotec SE access to Merck’s foundational CRISPR intellectual property.
|
20191112 |
|
|
10-ott-2019 |
Merck today announced it has acquired FloDesign Sonics, of Wilbraham, Massachusetts, USA, developer of a unique acoustic cell processing platform for the industrialization of cell and gene therapy manufacturing. Financial details were not disclosed.
|
20191010 |
|
|
19-set-2019 |
Merck has launched its official flagship store (merckls.1688.com) on Alibaba’s 1688.com.
|
20190919 |
|
|
19-ago-2019 |
Merck today announced that the European, Israeli, South Korean and U.K. intellectual property offices have issued formal notices allowing seven additional Merck patent application claims covering CRISPR gene-editing technology, bringing the number of patents to 20 worldwide.
|
20190819 |
|
|
06-ago-2019 |
Merck has acquired BSSN Software, a Darmstadt, Germany-based laboratory informatics company that makes data more readily accessible for ease of integration, collaboration, analysis and long-term archiving.
|
20190806 |
|
|
24-lug-2019 |
Merck today announced the signing of a non-binding Memorandum of Understanding (MoU) with Phanes Therapeutics, Inc. (Phanes) for a collaboration on the development and manufacture of biologics for the treatment of solid tumors.
|
20190724 |
|
|
18-lug-2019 |
Merck and the Broad Institute of MIT and Harvard (Boston, Massachusetts) today announced an agreement to offer non-exclusive licenses to CRISPR intellectual property (IP) under their respective control for use in commercial research and product development.
|
20190718 |
|
|
20-giu-2019 |
MilliporeSigma, EMD Serono and EMD Performance Materials make prestigious Massachusetts top employer list for 2019
|
20190620 |
Purificazione dell'acqua,Piccole molecole di interesse farmaceutico,Reagenti, prodotti chimici e attrezzature per il laboratorio,
Ricerche life science
,Microbiologia industriale,Kit, materiali e reagenti IVD/OEM,Produzione biofarmaceutica,Analisi e preparazione dei campioni |
|
20-giu-2019 |
Merck today announced a national campus tour in China for the company’s first mobile protein research laboratory.
|
20190620 |
|
|
30-mag-2019 |
Merck today announced the winners of its Advance Biotech Grant program in North America during its Biotech Start-up Summit at the Cambridge Innovation Center (Massachusetts, U.S.).
|
20190530 |
|
|
29-mag-2019 |
Merck today announced that students from St Aloysius’ College in Carrigtwohill have won the company’s 2019 School Science Competition, now in its 15th year.
|
20190529 |
|
|
27-mag-2019 |
Merck today announced the completion of a £2.7 million expansion to its Irvine biopharmaceutical production facility.
|
20190527 |
|
|
22-mag-2019 |
Merck today hosted a panel discussion on the occasion of the 72nd World Health Assembly in Geneva, Switzerland.
|
20190522 |
|
|
20-mag-2019 |
Merck today announced its participation in a collaboration with the Vaccine Formulation Institute and the European Vaccine Initiative.
|
20190520 |
|
|
07-mag-2019 |
Merck today announced that MDL, a team from Beijing University, has won the company’s first Retrosynthetic Reaction Prediction Contest.
|
20190507 |
|
|
30-apr-2019 |
Merck today announced the handover of a fully equipped microbiological testing laboratory to the Food Safety and Standards Authority of India (FSSAI).
|
20190430 |
|
|
24-apr-2019 |
Merck today launched Cyrene™ — a sustainable dipolar aprotic solvent, produced in two steps from a renewable cellulose source.
|
20190424 |
|
|
04-apr-2019 |
Merck today announced that it has won an INTERPHEX Exhibitor Award for a new innovation in advancing next-generation bioprocessing. Merck’s Pellicon® Capsule with Ultracel® Membrane has been recognized for Best New Product.
|
20190404 |
Produzione biofarmaceutica |
|
02-apr-2019 |
Merck today unveiled its BioContinuum™ Buffer Delivery Platform, a new building block in the BioContinuum™ Platform for next-generation bioprocessing.
|
20190402 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
20-mar-2019 |
Merck today officially opened its new M Lab™ Collaboration Center in Molsheim, France.
|
20190320 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
18-mar-2019 |
Merck today announced a new cloud-based, remote lab water service and monitoring capability available on all Milli-Q® CLX 7000 clinical water purification systems.
|
20190318 |
Purificazione dell'acqua |
|
19-mar-2019 |
Merck today announced the signing of a non-binding Memorandum of Understanding with Chinese biotech company GenScript for a strategic alliance focusing on plasmid and viral vector manufacturing.
|
20190319 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
14-mar-2019 |
Merck today announced a CRISPR core partnership with Zhejiang University in Hangzhou, China.
|
20190314 |
|
|
07-mar-2019 |
MilliporeSigma is igniting student interest in science with its third annual Curiosity Cube® mobile science lab tour.
|
20190307 |
Piccole molecole di interesse farmaceutico,
Ricerche life science
,Produzione biofarmaceutica |
|
04-mar-2019 |
Merck today announced that the Canadian Patent Office has allowed Merck’s patent application directed to the use of paired CRISPR nickases in eukaryotic cells.
|
20190304 |
Piccole molecole di interesse farmaceutico,
Ricerche life science
,Produzione biofarmaceutica |
|
19-feb-2019 |
Merck today announced that the United States Patent and Trademark Office has issued a formal notice allowing Merck’s patent application directed to its proxy-CRISPR technology.
|
20190219 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
04-feb-2019 |
Merck today announced the winners of its Advance Biotech Grant program in Europe.
|
20190204 |
Ricerche life science
|
|
15-gen-2019 |
Merck today announced that it has been recognized by BioInformatics LLC with a 2018 Life Science Industry Award® for best use of social media.
|
20190115 |
|
|
19-dic-2018 |
Merck today announced it has extended and expanded its collaboration with Kuraray Europe to exclusively supply pharmaceutical polyvinyl alcohol (PVA) grades and improvements to benefit the pharmaceutical market.
|
20181219 |
Ricerche life science
|
|
10-dic-2018 |
Merck today announced a strategic alliance in the CRISPR/Cas9 rodent model market with France-based biotechnology company genOway.
|
20181210 |
Ricerche life science
|
|
27-nov-2018 |
Merck today announced that it has won two R&D 100 Awards.
|
20181127 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
19-nov-2018 |
Merck recognized three graduate students who have demonstrated innovation in life science at an awards ceremony at the company’s global headquarters in Darmstadt, Germany recently.
|
20181119 |
Ricerche life science
|
|
05-nov-2018 |
Merck today launched its new BioContinuum™ Platform to advance biotherapeutic drug manufacturing through improved efficiency, simplified plant operations and greater quality and consistency.
|
20181105 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
18-ott-2018 |
Merck today announced the signing of a definitive agreement to sell its Flow Cytometry unit to Luminex Corporation for €62.5 million.
|
20181018 |
|
|
12-ott-2018 |
Merck announced that it has won two CPhI Pharma Awards for innovative products for the pharmaceutical industry.
|
20181012 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
04-ott-2018 |
Merck today officially opened a state-of-the-art M Lab™ Collaboration Center in Brazil, serving the Latin America region.
|
20181004 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
02-ott-2018 |
Merck recognized four graduate students for their research and innovations in synthetic organic chemistry as part of the Alfred R. Bader Student Chemistry Symposium in Darmstadt, Germany, on September 27.
|
20181002 |
|
|
18-set-2018 |
Merck today announced the opening of a new 3,800-square-meter laboratory in Singapore.
|
20180918 |
|
|
12-set-2018 |
Merck today announced the establishment of its first Mobius® Single-use Manufacturing Facility in China.
|
20180912 |
|
|
04-set-2018 |
Merck today launched three new products to help biomanufacturers navigate the evolving biopharma landscape with increased speed, greater flexibility and enhanced quality.
|
20180904 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
15-ago-2018 |
Merck today announced that the Australian Patent Office has allowed the company’s patent application for the use of paired CRISPR nickases.
|
20180815 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
26-lug-2018 |
Merck and InnoCore Pharmaceuticals; Groningen, Netherlands, have entered into a global cooperation agreement to provide InnoCore’s proprietary SynBiosys® biodegradable polymer platform.
|
20180726 |
Ricerche life science
|
|
02-lug-2018 |
Merck today announced plans to expand its Gillingham, UK distribution centre.
|
20180702 |
|
|
20-giu-2018 |
Merck today announced a new CRISPR core partnership with Tongji University in Shanghai.
|
20180620 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
19-giu-2018 |
Merck today announced that it has entered into an agreement with HistoCyte Laboratories Ltd, Tyne, U.K., to be the exclusive multinational distributor of the company’s portfolio of cell line reference products for immunohistochemistry and in situ hybridization.
|
20180619 |
Ricerche life science
|
|
12-giu-2018 |
Merck today announced that The American Journal of Bioethics has accepted a novel publication on ethical issues in genome editing to be printed in its July issue.
|
20180612 |
Ricerche life science
,Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
06-giu-2018 |
Merck today announced that it has successfully submitted a total of more than 1,000 registration dossiers under the European chemicals regulation REACH by the end of the third and final registration deadline of May 31, 2018.
|
20180606 |
|
|
05-giu-2018 |
Merck today officially opened North America’s first BioReliance® End-to-End Biodevelopment Center in Burlington, Massachusetts, U.S.A., providing cell line development services, upstream and downstream process development and non-GMP clinical production for drug manufacturers.
|
20180605 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
29-mag-2018 |
Merck today announced a collaboration with Solvias, a Swiss contract research and service provider, to offer the PyroMAT™ System, a new MAT kit for pyrogen detection.
|
20180529 |
Ricerche life science
|
|
16-mag-2018 |
Merck today announced a collaboration with Washington University in St. Louis, Missouri, USA, that could lead to the optimizing of nutritional supplements to restore a healthy gut microbial community (microbiome).
|
20180516 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
27-apr-2018 |
Merck today launched its new CellStream™ benchtop flow cytometry system, a compact, customizable flow cytometer that uses a camera for detection.
|
20180427 |
Ricerche life science
|
|
23-apr-2018 |
Merck today announced that the Chinese Patent Office has issued a notice granting Merck’s patent application for the company’s CRISPR technology used in a genomic-integration method for eukaryotic cells.
|
20180423 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
18-apr-2018 |
Merck today announced that its Millistak+® HC Pro portfolio has won an INTERPHEX Exhibitor Award for Best Technological Innovation.
|
20180418 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
17-apr-2018 |
Merck today introduced three new products to support flexible manufacturing of biologics.
|
20180417 |
|
|
12-apr-2018 |
Merck today announced a partnership with Oxford University’s Jenner Institute to develop more robust and scalable vaccine manufacturing processes.
|
20180412 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
28-mar-2018 |
Merck was named the overall “Best Bioprocessing Supplier” and won the sub-category of “Best Bioprocessing Supplier Award for Single-use Systems” at the Asia-Pacific Bioprocessing Excellence Awards 2018 ceremony.
|
20180328 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
05-mar-2018 |
Merck and Schneider Electric, a global specialist in energy management and automation, today announced the signing of a Memorandum of Understanding (MoU) that aims to automate the mAb process for China’s biopharmaceutical industry.
|
20180305 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
28-feb-2018 |
Merck today announced an expansion of its partnership with Seeding Labs to accelerate teaching and research for thousands of scientists in the developing world.
|
20180228 |
Ricerche life science
|
|
27-feb-2018 |
Merck today announced the recipients of its Emerging Biotech Grant Program in China.
|
20180227 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
26-feb-2018 |
MilliporeSigma today announced plans for its second annual Curiosity Cube™ mobile science lab tour, which will kick off in February and visit more than 100 communities in the U.S. and Canada.
|
20180226 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
22-feb-2018 |
Merck today announced that it will invest €16.6 million in its new manufacturing and distribution centre for the Life Science business, located near Mumbai, India.
|
20180222 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
22-feb-2018 |
Merck today announced it has signed an agreement with Incheon Free Economic Zone (IFEZ) to build an integrated cell culture facility in Songdo, Incheon.
|
20180222 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
22-feb-2018 |
Merck today announced an additional investment to accelerate Mobius® single-use manufacturing in Wuxi, China.
|
20180222 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
22-feb-2018 |
Merck today announced nine new or expanded partnerships with leading nonprofit organizations across the world through its Life Science business sector.
|
20180222 |
|
|
21-feb-2018 |
Merck today announced an additional investment of €40 million to build a robust manufacturing and distribution platform in Asia over a span of two years.
|
20180221 |
|
|
20-feb-2018 |
Merck today announced that the Korean Intellectual Property Office and the Israel Patent Office have each issued notices granting Merck’s patent applications for the company’s CRISPR technology.
|
20180220 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
13-feb-2018 |
Merck today introduced Viresolve® Barrier capsule filters to reduce the risk of bioreactor contamination.
|
20180213 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
01-feb-2018 |
For the second year in a row, the North American businesses of Merck KGaA, Darmstadt, Germany, a leading science and technology company, have been certified for the company’s outstanding employee offerings by the independent Top Employers Institute.
|
20180201 |
|
|
20-dic-2017 |
Merck today announced a collaboration with IPS-Integrated Project Services, LLC and G-CON Manufacturing, Inc. to provide the most advanced 2,000L monoclonal antibody (MAb) facility and single-use process technology platform.
|
20171220 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
20-dic-2017 |
Merck today announced that it has signed a commercial supply agreement to manufacture viral vectors for bluebird bio, Inc., of Cambridge, Massachusetts, USA, for its use in potentially transformative gene therapies.
|
20171220 |
|
|
19-dic-2017 |
Merck today announced that the Intellectual Property Office of Singapore has issued a “Notice of Eligibility for Grant” for Merck’s patent application covering the company’s CRISPR technology.
|
20171219 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
11-dic-2017 |
Merck today announced that it has entered into an agreement with Avanti® Polar Lipids to be the exclusive multinational distributor of the USA-based company’s research lipids portfolio outside of the United States.
|
20171211 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
17-nov-2017 |
Merck KGaA, Darmstadt, Germany today announced that its Massachusetts-based business sectors, EMD Serono and MilliporeSigma, have been named to The Boston Globe's annual "Top Places to Work" list for the second year in a row.
|
20171117 |
|
|
13-nov-2017 |
Merck today launched the new Stericup® Quick Release 500 ml vacuum filtration system.
|
20171113 |
Ricerche life science
|
|
01-nov-2017 |
Merck today announced the signing of a Memorandum of Understanding (MoU) with Samsung BioLogics for a strategic alliance on biopharmaceutical manufacturing and biologics process development.
|
20171101 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
24-ott-2017 |
Merck today announced that the Canadian Patent Office has issued a “Notice of Allowance” for Merck’s patent application covering the company’s CRISPR technology.
|
20171024 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
23-ott-2017 |
Merck has recognized a group of outstanding postgraduate students for their research and innovations in life science at an awards ceremony.
|
20171023 |
|
|
19-ott-2017 |
Merck today announced that its Carlsbad, California-based manufacturing facility for the production of BioReliance® viral and gene therapy products has completed both a U.S. Food & Drug Administration (FDA) Pre-License inspection and a European Medicines Agency (EMA) Marketing Authorization Application inspection.
|
20171019 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
11-ott-2017 |
MilliporeSigma will welcome world-renowned academic researchers, technology experts and industry entrepreneurs to discuss advances and opportunities in some of the most exciting areas of life science on Wednesday, October 11, 2017, 10 a.m. at the company’s new Life Science Center in Burlington.
|
20171011 |
|
|
10-ott-2017 |
Merck will host a panel discussion, “The Personalized Cell Therapy Challenge: A Race Against Time,” featuring leading cell and gene therapy experts from academia, hospitals and industry.
|
20171010 |
|
|
10-ott-2017 |
Merck will welcome world-renowned academic researchers, technology experts and industry entrepreneurs to discuss advances and opportunities in some of the most exciting areas of life science on Wednesday, October 11, 2017, 10 a.m. at the company’s new Life Science Center in Burlington.
|
20171010 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
27-set-2017 |
Merck today announced an update on its participation in Horizon 2020, the EU Framework Program for Research and Innovation, to improve biopharmaceutical downstream processing.
|
20170927 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
26-set-2017 |
Merck today announced Millistak+® HC Pro, the first portfolio of high- capacity, fully synthetic depth filters for non-treated Chinese Hamster Ovary (CHO) harvest clarification and downstream filtration applications.
|
20170926 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
22-set-2017 |
Merck today announced the opening of its first BioReliance® End-to-End Biodevelopment Center in the Asia Pacific (APAC) region.
|
20170922 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
20-set-2017 |
Merck today launched Eshmuno® P anti-A and Eshmuno® P anti-B affinity chromatography resins specifically designed to remove anti-A and anti-B isoagglutinin antibodies during the manufacturing of plasma-derived immunoglobulin (Ig) therapies.
|
20170920 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
13-set-2017 |
Merck today announced that Celonic AG, a Swiss contract development and manufacturing organization (CDMO), is upgrading its manufacturing facility with five of Merck’s Mobius® single-use bioreactors.
|
20170913 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
11-set-2017 |
Merck recognized four student chemists for their research and innovations in synthetic organic chemistry as part of the Alfred R. Bader Student Chemistry Symposium.
|
20170911 |
|
|
28-ago-2017 |
Merck today announced that it has entered into an agreement to acquire Natrix Separations, an Ontario, Canada-based provider of hydrogel membrane products for single-use chromatography.
|
20170828 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
30-ago-2017 |
Merck has opened its first global Food Safety Studio in Bellevue, Washington for manufacturers of all types of food to collaborate with Merck scientists.
|
20170830 |
Analisi e preparazione dei campioni |
|
29-ago-2017 |
Merck today announced a new collaboration with Angiex, Inc., Cambridge, Massachusetts, to support the biotechnology start-up’s ability to speed its lead oncology antibody drug candidate to clinical use.
|
20170829 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
08-ago-2017 |
Merck today announced that it has formed a strategic alliance with Baylor College of Medicine...
|
20170808 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
03-ago-2017 |
Merck today announced that the European Patent Office (EPO) has issued a “Notice of Intention to Grant” for Merck’s patent application covering the company’s CRISPR technology used in a genomic integration method for eukaryotic cells.
|
20170803 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
27-giu-2017 |
Merck today announced that it has prevailed against Analis S.A. in a lawsuit ordering the Belgium-based laboratory equipment distributor to cease advertising that compares RephiLe Bioscience Ltd.’s lab water products with the lab water products of Merck.
|
20170627 |
Purificazione dell'acqua |
|
26-giu-2017 |
Merck today announced a collaboration with Elsevier, the information analytics company specializing in science and health, to add its products into Reaxys, Elsevier’s chemistry database.
|
20170626 |
Reagenti, prodotti chimici e attrezzature per il laboratorio |
|
15-giu-2017 |
Merck today announced an expansion of its distribution alliance with Public Health England (PHE) to include the European Bank of induced pluripotent Stem Cells (EBiSC).
|
20170615 |
|
|
14-giu-2017 |
Merck today announced that the Australian Patent Office has granted the company patent rights over the use of CRISPR in a genomic integration method for eukaryotic cells.
|
20170614 |
Ricerche life science
|
|
16-mag-2017 |
Merck today announced that its CHOZN® expression system will be used by SystImmune, a Seattle-based biotechnology company, for commercial development of a bi-specific antibody therapeutic.
|
20170516 |
Ricerche life science
|
|
17-mag-2017 |
Merck has developed a new genome editing tool that makes CRISPR more efficient, flexible and specific.
|
20170517 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
15-mag-2017 |
Merck today took a significant step toward increasing manufacturing flexibility and enabling higher productivity with the launch of the EX-CELL® Advanced™ HD Perfusion Medium.
|
20170515 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
12-mag-2017 |
Merck today announced the expansion of its M Lab™ Collaboration Center in Bangalore, India.
|
20170512 |
|
|
12-mag-2017 |
Merck today announced the opening of its first joint Process Scale-Up Lab in Bengaluru, India to provide end-to-end solutions from process development to scale-up manufacturing for pre-clinical, clinical and commercial supply.
|
20170512 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
09-mag-2017 |
Merck today announced the acquisition of Grzybowski Scientific Inventions (GSI), a company that developed the revolutionary computer-aided retro-synthesis tool, Chematica.
|
20170509 |
|
|
01-mag-2017 |
MilliporeSigma and Avid Bioservices, Inc., today announced that Avid will upgrade its Myford clinical and commercial manufacturing facility with multiple Mobius® 2000-liter single-use bioreactors from MilliporeSigma.
|
20170501 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
25-apr-2017 |
MilliporeSigma announced today that the company will sponsor the Startup Program at LabCentral, a biotechnology incubator, in Cambridge, Massachusetts.
|
20170425 |
|
|
20-apr-2017 |
Merck has announced that BioInvent International AB, a Swedish company which develops novel immuno-regulatory antibodies to treat cancer, is upgrading and expanding its drug manufacturing facility with a full line of MilliporeSigma’s Mobius® single-use bioreactors.
|
20170420 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
05-apr-2017 |
MilliporeSigma has announced nine stops for the first half of its national, year-long Curiosity Cube™ tour.
|
20170405 |
|
|
03-apr-2017 |
Merck today announced the launch of its newest high-sensitivity detection platform, SMCxPRO™ technology, at the American Association for Cancer Research Annual Meeting in Washington, D.C.
|
20170403 |
Ricerche life science
|
|
21-mar-2017 |
Merck today launched the Mobius® MyWay portfolio, a program that allows more flexibility, better supply predictability and shorter lead times for more efficient and safer drug manufacture.
|
20170321 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
06-mar-2017 |
Merck today announced the global launch of the Milli-Q® IQ 7000 system, the seventh-generation Milli-Q® water purification innovation.
|
20170306 |
Purificazione dell'acqua |
|
15-feb-2017 |
Merck was selected by contract development and manufacturing organization WuXi Biologics to provide Merck’s Mobius® single-use systems and technologies to fully equip a non-GMP pilot plant in Shanghai, China.
|
20170215 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
08-feb-2017 |
Merck KGaA, Darmstadt, Germany has announced that its North American businesses have been certified by the Top Employers Institute for exceptional employee offerings.
|
20170208 |
|
|
03-feb-2017 |
Merck has received the 2017 Scotland’s Life Science Award for outstanding achievements in community engagement.
|
20170203 |
|
|
23-gen-2017 |
Merck today announced the winners of its Emerging Biotech Grant Program in Europe.
|
20170123 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
12-gen-2017 |
Recognizing that tomorrow’s discoveries depend on the next generation of scientists, MilliporeSigma has kicked off a year-long “Curiosity Cube™” tour.
|
20170112 |
|
|
10-gen-2017 |
Merck today announced the expansion of its end-to-end biodevelopment centers to meet increasing customer demand for its turnkey portfolio of bioprocessing products, manufacturing capabilities and industry leading technological expertise.
|
20170110 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
04-gen-2017 |
Merck today announced it has acquired BioControl Systems Inc., a global leader in food safety testing.
|
20170104 |
Produzione biofarmaceutica |
|
18-gen-2017 |
Merck has introduced CAN MultiFlow™ screening services to more accurately predict genotoxic and mode of action* properties of substances, ingredients and drug compounds
|
20170118 |
|
|
13-gen-2017 |
Merck today announced the introduction of its new testosterone calibrator kit for in vitro diagnostic (IVD) use.
|
20170113 |
|
|
17-gen-2017 |
Merck today announced the opening of a facility in Mollet des Vallès, Spain dedicated to the manufacture of meglumine, an FDA-approved excipient for pharmaceuticals and a component of medical imaging contrast media.
|
20170117 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
19-dic-2016 |
MilliporeSigma today announced that Ying Li, from The Pennsylvania State University, has won the company’s Life Science Award in Bioseparations.
|
20161219 |
|
|
16-dic-2016 |
MilliporeSigma today announced that it has been recognized by BioInformatics LLC with a 2016 Life Science Industry Award® for most memorable advertising.
|
20161216 |
|
|
05-dic-2016 |
Merck today announced that it will provide its Provantage® End-to-End services to Acticor Biotech SAS for accelerated development and manufacturing of Acticor’s antibody fragment used for the primary treatment of ischemic stroke.
|
20161205 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
02-dic-2016 |
Merck today introduced Parteck® MXP, a polyvinyl alcohol-based excipient that enhances solubility of a wide range of active pharmaceutical ingredients (APIs) with poor bioavailability.
|
20161202 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
02-dic-2016 |
Merck today launched the MILLIPLEX® MAP Human High Sensitivity cytokine panel for faster and more cost-effective human cytokine assays.
|
20161202 |
Ricerche life science
|
|
01-dic-2016 |
Merck today announced an expansion of its distribution alliance with Roche to include the polymerase chain reaction (PCR) and quantitative real-time PCR (qPCR) enzyme products of Kapa Biosystems, a company acquired by Roche in 2015.
|
20161201 |
|
|
30-nov-2016 |
Merck today announced that it has entered into a set of agreements with Evotec AG, whereby Evotec AG will provide screening services for Merck’s collection of genetic reagents such as CRISPR and shRNA libraries.
|
20161130 |
|
|
18-nov-2016 |
MilliporeSigma today announced that it has been named to The Boston Globe’s annual “Top Places to Work” list.
|
20161118 |
|
|
15-nov-2016 |
MilliporeSigma today announced that its digital acquisition marketing team won the 2016 US Search award for “Best In-House” team.
|
20161115 |
|
|
14-nov-2016 |
Merck has launched the CellASIC® ONIX2 Microfluidic System for advanced live cell imaging.
|
20161114 |
Ricerche life science
|
|
11-nov-2016 |
Merck received a prestigious R&D 100 Award for its Sanger Arrayed Lentiviral CRISPR Libraries—the first of its kind CRISPR libraries.
|
20161111 |
|
|
13-ott-2016 |
Merck today introduced the first Certified Spiking Solution® of intact, heavy labeled Thyroglobulin in SigMatrix®, a synthetic surrogate serum.
|
20161013 |
Reagenti, prodotti chimici e attrezzature per il laboratorio,Kit, materiali e reagenti IVD/OEM,Analisi e preparazione dei campioni |
|
06-ott-2016 |
Merck today announced the opening of an M Lab™ Collaboration Center in the Songdo district of Incheon, Korea, one of the fastest growing biotech hubs in Asia.
|
20161006 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
05-ott-2016 |
Merck today announced that the CEO of its life science business, Udit Batra, was named “CEO of the Year” for 2016 by CPhI Pharma for his commitment to furthering life science innovation globally.
|
20161005 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
26-set-2016 |
Merck is launching the Viresolve® Pro Shield H for removal of parvoviruses from therapeutic protein feed streams.
|
20160926 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
19-set-2016 |
Merck has introduced a set of Steritest™ Symbio Pump systems accessories that accelerate and streamline sterility testing workflows.
|
20160919 |
Microbiologia industriale |
|
14-set-2016 |
Merck has joined the DiViNe project, a European consortium of six companies to address the biggest challenges facing the development, manufacture and delivery of vaccines.
|
20160914 |
|
|
13-set-2016 |
Merck today announced that its microbiology quality control laboratory in Eppelheim, Germany is now accredited for the quality control of the ReadyPlate™ and ReadyTube™ culture media tested there.
|
20160913 |
Microbiologia industriale |
|
08-set-2016 |
Merck today launched a first-of-its-kind gene editing technology to modify CHO cell lines to be resistant to minute virus of mice (MVM), a common contamination threat that remains despite the shift to chemically defined, animal component-free manufacturing processes.
|
20160908 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
03-ago-2016 |
Merck today announced the expansion of its portfolio of Cerilliant® certified reference materials (CRMs) with nine new Certified Spiking Solutions® used in laboratories around the world.
|
20160803 |
Reagenti, prodotti chimici e attrezzature per il laboratorio,Analisi e preparazione dei campioni |
|
01-ago-2016 |
Merck will provide its Provantage® End-to-End development and manufacturing services to Y-mAbs Therapeutics, Inc. in support of Y-mAbs’ monoclonal antibody in late stage clinical development.
|
20160801 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
19-lug-2016 |
Merck today announced plans to build a new campus in Burlington, Massachusetts that will serve as a major hub for the North American life science business of Merck.
|
20160719 |
|
|
18-lug-2016 |
Merck is relaunching its global network of customer collaboration centers, providing customers a shared, exploratory environment with scientists and engineers working to solve their toughest biomanufacturing challenges and helping accelerate development of new therapies.
|
20160718 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
13-lug-2016 |
Merck today introduced the Elix® High-Throughput water purification system, providing laboratories with a reliable water purification solution for daily water volumes of up to 9000 liters.
|
20160713 |
Purificazione dell'acqua |
|
12-lug-2016 |
Merck has entered into an agreement with PCAS S.A. (Longjumeau, France) to expand Merck’s excipients portfolio.
|
20160712 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
28-giu-2016 |
Merck has expanded its industry-leading Emprove® risk assessment program to include a selection of products for filtration and single-use processing.
|
20160628 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
28-giu-2016 |
Merck has entered a research agreement with the International Vaccine Institute (IVI) of Seoul, South Korea to help develop more robust, scalable vaccine manufacturing processes.
|
20160628 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
07-giu-2016 |
Merck today announced survey results of 250 global biopharmaceutical executives on how their companies will manage new risks associated with the changing biopharma landscape.
|
20160607 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
11-mag-2016 |
Merck is expanding its popular line of Guava® flow cytometers to include a high-power modulated green laser.
|
20160511 |
Ricerche life science
|
|
10-mag-2016 |
Merck will exhibit a new range of products and solutions at Analytica 2016, the international trade fair for laboratory technology, analysis and biotechnology, held May 10-13 in Munich, Germany.
|
20160510 |
Purificazione dell'acqua,Reagenti, prodotti chimici e attrezzature per il laboratorio,
Ricerche life science
,Microbiologia industriale,Kit, materiali e reagenti IVD/OEM,Analisi e preparazione dei campioni |
|
09-mag-2016 |
Merck today announced the global launch of the first commercially-available equine-specific multiplex assay for protein biomarkers.
|
20160509 |
Ricerche life science
|
|
04-mag-2016 |
Merck today announced an expansion of its Carlsbad, California facility to meet growing demand for viral and gene therapy products.
|
20160504 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
02-mag-2016 |
Merck today announced the expansion of its state-of-the art single use current good manufacturing process (cGMP) facility with the addition of the Mobius® 2000L single-use bioreactor.
|
20160502 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
27-apr-2016 |
Merck is launching three Mobius® products that deliver improved efficiency and ease-of-use for biopharmaceutical manufacturing workflows.
|
20160427 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
26-apr-2016 |
Merck today announced the launch of its first-in-class Lynx® CDR connectors to improve fluid management in the biopharma industry.
|
20160426 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
19-apr-2016 |
Merck has received accreditation for the quality control of dehydrated culture media tested at its Microbiology Quality Control Laboratory in Darmstadt.
|
20160419 |
Microbiologia industriale |
|
14-apr-2016 |
Merck today announced that it is participating in the 4th USA Science & Engineering Festival (USASEF), April 16-17, 2016 in Washington D.C.
|
20160414 |
|
|
29-mar-2016 |
Merck today announced that The Scientist magazine has named the company’s CRISPR Epigenetic Activator one of its Top 10 Innovations of 2015.
|
20160329 |
Ricerche life science
|
|
21-mar-2016 |
Merck today introduced the IsoBag™ for faster, easier and more convenient transfer of contact and settle plates to production isolators.
|
20160321 |
Microbiologia industriale |
|
07-mar-2016 |
Merck is launching a range of new products for separation and analysis at the Pittcon Conference and Expo 2016 in Atlanta, Georgia, March 6 – 10, the world’s largest conference for laboratory science.
|
20160307 |
Purificazione dell'acqua,Reagenti, prodotti chimici e attrezzature per il laboratorio,Microbiologia industriale,Analisi e preparazione dei campioni |
|
07-mar-2016 |
Merck today announced the launch of SPARK, a global skills-based volunteer program that provides community service opportunities for its network of nearly 19,000 life science employees, with a focus on science and education.
|
20160307 |
|
|
08-gen-2016 |
Merck today announced it has donated $10,000 to the American Red Cross of the Greater St. Louis Region in support of the organization’s flood relief efforts.
|
20160108 |
|
|
16-dic-2015 |
Merck today announced it has received two prestigious R&D Magazine 100 awards – one for its lab water purification systems, and the other for a technology that allows researchers to investigate scientific questions they previously couldn’t address.
|
20151216 |
Purificazione dell'acqua,Piccole molecole di interesse farmaceutico,
Ricerche life science
,Produzione biofarmaceutica |
|
18-nov-2015 |
Merck ha oggi annunciato il perfezionamento dell'acquisizione da 17 miliardi di $ di Sigma-Aldrich con cui ha dato vita a uno degli attori principali di questo settore, che nel mondo vale 130 miliardi di dollari, per contribuire a risolvere i problemi più difficili delle life science.
|
20151118 |
|
|
20-nov-2015 |
Merck today hosted a discussion with renowned researchers to discuss the intention to launch its innovative Muse® Auto CD4/CD4% System, a portable instrument for monitoring T cells and CD4 counts throughout Africa.
|
20151120 |
Ricerche life science
|
|
18-nov-2015 |
Merck today announced the launch of its innovative Muse® Auto CD4/CD4% System, a portable instrument for monitoring T cells and CD4 counts in HIV affected patients in Nigeria.
|
20151118 |
Ricerche life science
|
|
09-nov-2015 |
Merck today introduced the new AldeRed™ ALDH Detection Kit for identifying and isolating cancer stem cells.
|
20151109 |
Ricerche life science
|
|
26-ott-2015 |
Merck today introduced Parteck® SRP 80, a new functional excipient for oral sustained-release formulations.
|
20151026 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
22-ott-2015 |
Merck today announced the Company has entered into a strategic alliance with Turgut Ilaç, a leading biosimilars company based in Turkey and will provide their Provantage® End-to-End services for development and manufacturing of biologics.
|
20151022 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
21-ott-2015 |
Merck today introduced Millipore Express® PHF (process protection, high-flux) hydrophilic filters for fast, efficient and economical buffer filtration.
|
20151021 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
28-set-2015 |
Merck today announced that it has published an original white paper, recognizing the impact the emerging biotech community has on the future of healthcare.
|
20150928 |
Purificazione dell'acqua,Piccole molecole di interesse farmaceutico,Reagenti, prodotti chimici e attrezzature per il laboratorio,
Ricerche life science
,Microbiologia industriale,Kit, materiali e reagenti IVD/OEM,Produzione biofarmaceutica,Analisi e preparazione dei campioni |
|
14-set-2015 |
Merck today introduced enhancements to its industry-leading Emprove® portfolio of pharmaceutical raw materials.
|
20150914 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
12-ago-2015 |
Merck today announced it is providing the Massachusetts Institute of Technology (MIT) with a $50,000 charitable contribution to support the development of a novel diagnostic and tracking platform for Ebola.
|
20150812 |
|
|
27-lug-2015 |
Merck today announced a collaboration with celares GmbH to provide pegylation services to customers developing protein-based therapeutics and biosimilars.
|
20150727 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
16-giu-2015 |
Merck today announced three additions to its MAS-100® product family.
|
20150616 |
Microbiologia industriale |
|
15-giu-2015 |
Merck today introduced the Mobius® 2000 liter single-use bioreactor. The 2000 liter bioreactor joins the Mobius® stirred tank bioreactor portfolio (from 3 to 2000 liters) that provides the ultimate in flexibility, scalability, and convenience.
|
20150615 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
15-giu-2015 |
Merck today announced expansion of its Provantage® Biodevelopment Services to include a Clone Generation Service.
|
20150615 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
02-giu-2015 |
Merck today introduced a new technology that compacts dry powder cell culture media into granules, accelerating solubility and improving flowability and handling.
|
20150602 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
01-giu-2015 |
Merck today announced that Nancy Hopkins, Ph.D., Amgen, Inc. Professor of Biology (emerita), Biology Department and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT), is the recipient of the 2015 Merck Alice C. Evans Award for Leadership in Clinical Microbiology.
|
20150601 |
Microbiologia industriale |
|
01-giu-2015 |
Merck today announced the launch of its Cellvento™ CHO platform of cell culture media and companion feed formulations for batch, fed-batch and perfusion applications.
|
20150601 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
21-mag-2015 |
Merck today introduced single-pass tangential flow filtration (TFF) with Pellicon® cassettes, an enhanced application of Merck’s existing TFF technology that allows concentration of process streams without the recirculation required in traditional TFF.
|
20150521 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
21-mag-2015 |
Merck and Singulex, the developer and leading provider of Single Molecule Counting (SMCTM) technology for clinical diagnostics and scientific discovery, today announced that they have entered into a definitive agreement under which Merck will control and manage the Singulex Life Science Research business.
|
20150521 |
Ricerche life science
|
|
06-mag-2015 |
Merck announced publication of a study showing that its Strat-M® synthetic membrane predicts skin permeation of chemical compounds during in vitro transdermal diffusion studies as effectively as human or animal skin.
|
20150506 |
Ricerche life science
|
|
23-apr-2015 |
Merck today introduced Magna ChIRP™ RNA Interactome Kits, which allow researchers to more easily identify, recover and analyze regions of chromatin that interact with chromatin-associated RNAs such as long non-coding RNA (lncRNA).
|
20150423 |
Ricerche life science
|
|
02-feb-2015 |
Merck today announced an agreement for providing upstream process development services for Precision Biologics, Inc., a Texas-based clinical-stage biotechnology company, to advance a preclinical monoclonal antibody.
|
20150202 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
27-gen-2015 |
Merck ha oggi presentato i suoi nuovi sistemi di purificazione dell'acqua AFS® 40E / 80E / 120E e 150E.
|
20150127 |
Purificazione dell'acqua |
|
19-nov-2014 |
Merck today introduced the Amnis® NFкB Translocation kit, which allows researchers to better study the nuclear translocation of NFкB, a transcription factor that plays a central role in regulating key mammalian cell processes, including proliferation, inflammation, immune and stress responses.
|
20141119 |
Ricerche life science
|
|
21-ott-2014 |
Merck has expanded its single-use film offerings with the introduction of PureFlex™ Plus film, a robust, durable film used in the construction of Mobius® single-use process containers for biopharmaceutical manufacturing.
|
20141021 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
06-nov-2014 |
Merck offers new data demonstrating improved performance for its guava easyCyte™ 12 flow cytometer, a simple and powerful benchtop method for multicolor flow cytometry.
|
20141106 |
Ricerche life science
|
|
03-nov-2014 |
Merck has introduced the SNAP i.d.® 2.0 Protein Detection System for Immunohistochemistry (IHC), which streamlines immunohistochemistry workflows and significantly decreases slide handling time.
|
20141103 |
Ricerche life science
|
|
22-set-2014 |
Merck today announced that they have entered into a definitive agreement under which Merck will acquire Sigma-Aldrich for $17.0 billion (€13.1 billion), establishing one of the leading players in the $130 billion global life science industry.
|
20140922 |
|
|
15-set-2014 |
Merck announced it has received two R&D Magazine 100 Awards for innovative products released to market in 2013.
|
20140915 |
Piccole molecole di interesse farmaceutico,
Ricerche life science
,Produzione biofarmaceutica |
|
28-ago-2014 |
Merck has launched Steritest™ Symbio Pumps for easier, safer and more reliable sterility testing of pharmaceutical products in laminar flow hoods, isolators and clean rooms.
|
20140828 |
Microbiologia industriale |
|
26-ago-2014 |
Merck today announced the opening of a new Biomanufacturing Sciences Training Center (BSTC) facility in Tokyo.
|
20140826 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
20-ago-2014 |
Merck announced today that Merck and Samsung BioLogics signed an MOU (Memorandum of Understanding) for a strategic alliance on the biopharmaceutical business.
|
20140820 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
05-mag-2014 |
Merck Millipore today announces the expansion of its upstream services into North America as part of its Provantage® Biodevelopment and Clinical Supply offering.
|
20140505 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
09-apr-2014 |
The contract includes a range of Merck Millipore products and reagents for chemical and microbiological analysis
|
20140409 |
Reagenti, prodotti chimici e attrezzature per il laboratorio,Microbiologia industriale,Analisi e preparazione dei campioni |
|
17-mar-2014 |
This collaboration will use Merck Millipore’s flow cytometry technology as a platform to accelerate the creation of new, more powerful diagnostic tools for research in blood disorders.
|
20140317 |
Ricerche life science
|
|
10-mar-2014 |
This is one of four grants given to Life Science companies in Massachusetts to fund international collaboration as part of MLSC’s International Collaborative Industrial Program.
|
20140310 |
Ricerche life science
|
|
04-feb-2014 |
The DRYPOUR™ packaging system minimizes caking of hygroscopic salts used in pharmaceutical manufacturing during transport and storage.
|
20140204 |
Produzione biofarmaceutica,Piccole molecole di interesse farmaceutico |
|
29-gen-2014 |
The portfolio includes EMPROVE® api for active pharmaceutical ingredients, EMPROVE® exp for excipients and EMPROVE® bio for biopharmaceutical materials.
|
20140129 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
17-dic-2013 |
Merck Millipore offrirà donazioni sotto forma di prodotti e denaro per coloro che sono stati severamente colpiti del tifone Haiyan nelle Filippine.
|
20131217 |
Microbiologia industriale |
|
23-ott-2013 |
By eliminating the need to isolate genomic DNA prior to performing bisulfite analysis, the kit provides a simple and reliable protocol for one-step bisulfite conversion.
|
20131023 |
Ricerche life science
|
|
08-nov-2013 |
The Direct Detect® system was recognized as one of R&D Magazine’s 100 most innovative and technologically significant products to be introduced into the marketplace.
|
20131108 |
Ricerche life science
|
|
07-nov-2013 |
The donation will specifically support EESI’s Transportation and Communities Program, which emphasizes energy efficiency and renewable energy across the transportation sector.
|
20131107 |
|
|
16-ott-2013 |
MicroRNA detection with SmartRNAplex requires just three steps: hybridize, label, and report.
|
20131016 |
Ricerche life science
|
|
22-ott-2013 |
Featuring a unique pore structure, Parteck SLC for drug delivery enables loading of oral dosage forms with amorphously distributed API to the highest levels.
|
20131022 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
22-ott-2013 |
The electronic Original Manufacturer Tracking (eOMT) saves users valuable time in research and enables compliance with regulatory requirements.
|
20131022 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
10-ott-2013 |
The Court determined that RephiLe’s accused products fall into the protection scope of Merck Millipore’s patent.
|
20131010 |
|
|
12-set-2013 |
Merck Millipore today announced that its Biodevelopment Centre in Martillac, France, has been recertified by the French National Agency for Medicines and Health Products Safety (ANSM), the competent authority of France.
|
20130912 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
26-set-2013 |
These awards were distributed by the American Business Awards, the premier business award program in the United States - finalists were announced in June.
|
20130926 |
Ricerche life science
|
|
19-apr-2012 |
The “Live Lab,” a 60-square-meter exhibition space housed in an eye-catching coach-style vehicle, is a novel way to bring information about new technologies right to the workplace.
|
20120419 |
Purificazione dell'acqua |
|
07-feb-2012 |
The new systems integrate patented Elix electrodeionization (EDI) technology along with several other complementary water purification techniques.
|
20120207 |
Purificazione dell'acqua |
|
25-gen-2012 |
First launched in 2005, the Direct-Q systems met with immediate and continuing success
|
20120125 |
Purificazione dell'acqua |
|
21-feb-2012 |
The Merck Millipore AFS 10E and AFS 15E water purification systems integrate patented Elix® electrodeionization (EDI) technology along with several other complementary water purification techniques
|
20120221 |
Purificazione dell'acqua |
|
19-giu-2012 |
The new systems are designed to provide cost-effective, low-maintenance solutions for clinical analyzers requiring degassed clinical laboratory reagent water (CLRW).
|
20120619 |
Purificazione dell'acqua |
|
25-mag-2011 |
Water for Cell Culture and Water for Molecular Biology are produced in an ISO® 9001 / cGMP environment. The bottled water is subject to strict quality control tests.
|
20110525 |
Purificazione dell'acqua |
|
08-mar-2011 |
The Elix Gulfstream Clinical water purification system will provide up to 100 liters per hour and 2000 liters of clinical laboratory reagent water (CLRW) daily
|
20110308 |
Purificazione dell'acqua |
|
18-set-2013 |
Merck Millipore Teams Up with the Vince Wilfork Foundation to Donate Backpacks and School Supplies to Boston-Area Students
|
20130918 |
|
|
16-set-2013 |
Merck Millipore Named One of the Top Charitable Contributors by the Boston Business Journal
|
20130916 |
|
|
17-set-2013 |
Novel Clarisolve Depth Filters Deliver Unmatched Speed and Efficiency for Single-Stage Clarification of Pretreated Feed Streams
|
20130917 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
10-set-2013 |
Merck Millipore today announced a $30,000 donation to charity: water in recognition of World Water Week.
|
20130910 |
|
|
12-lug-2013 |
The center will accelerate growth of the company’s portfolio of innovative technologies and products that overcome bioavailability and formulation challenges
|
20130712 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
06-giu-2013 |
The Muse™ Cell Analyzer provides greater accuracy and precision than manual hemocytometry or image-based automated analysis.
|
20130606 |
Ricerche life science
|
|
20-mag-2013 |
Since 2011, Merck Millipore has supported the Vince Wilfork Foundation and its efforts to fund critical research at several leading diabetes institutions.
|
20130520 |
|
|
12-giu-2013 |
The proprietary formulation includes Activin-A, TGFβ1, and b-FGF to promote stem cell self-renewal and potent small molecule combinations to inhibit unwanted spontaneous differentiation.
|
20130612 |
Ricerche life science
|
|
24-giu-2013 |
Cellvento™ CHO-200 medium and its corresponding feeds do not contain hydrolysates or components of unknown composition, resulting in very good lot-to-lot consistency.
|
20130624 |
Produzione biofarmaceutica |
|
08-lug-2013 |
This year’s recipients are Emily Caron, daughter of Merck Millipore employee Roger Caron and Alexander Murphy, stepson of Merck Millipore employee Heather Sue Murphy.
|
20130708 |
|
|
10-lug-2013 |
As a leading supplier of tools and technologies that support research for many chronic diseases including MS, Merck Millipore is proud to support the National Multiple Scleroses Society.
|
20130710 |
|
|
15-mar-2012 |
This new single-use bioreactor allows biopharmaceutical manufacturers to implement robust, single-use technologies that bring their drugs to market faster, with less risk.
|
20120315 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
27-feb-2012 |
The opening of this lab water production facility marks another milestone for Merck Millipore in China, reflecting its long term commitment to the market.
|
20120227 |
Purificazione dell'acqua |
|
08-mag-2013 |
Christina Shasserre was recognized for Merck Millipore’s support of JDRF, which includes serving as the chair sponsor of the annual “Walk to Cure Diabetes.”
|
20130508 |
|
|
10-mag-2013 |
This award recognizes a Massachusetts firm, institution or public agency of any size that has demonstrated excellence in international trade.
|
20130510 |
|
|
14-mag-2013 |
These new kits enable target chromatin enrichment from both low and high amounts of input chromatin while delivering low backgrounds, high signal-to-noise ratios, and ultra-sensitive detection.
|
20130514 |
Ricerche life science
|
|
21-mag-2013 |
The companies will work together to produce protocols and methods for efficient expansion, harvest and use of HepaRG® cells in support of the BALANCE project.
|
20130521 |
Produzione biofarmaceutica |
|
25-giu-2012 |
Donovan joined Millipore Corporation in 1988 and has held numerous sales leadership roles including Senior Director, North American Field Operations, and Director of Sales.
|
20120625 |
Produzione biofarmaceutica |
|
04-giu-2012 |
This new application facilitates large-scale production at up to one-third the cost per dose compared to cells grown in flat culture stacks.
|
20120604 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
16-mag-2012 |
This list, created by LexisNexis Matindale-Hubbell, is a peer-reviewed rating of the leading local lawyers who have reached the highest levels of ethical standards and professional excellence.
|
20120516 |
|
|
01-mag-2013 |
He will assume leadership effective May 14, 2012 and be based at the company’s U.S. headquarters in Massachusetts.
|
20130501 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
12-feb-2012 |
With the Millistak+ µPod filter, users can easily connect multiple devices in parallel or series to rapidly screen combinations of media.
|
20120212 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
27-feb-2012 |
Merck Millipore and Charles River will collaborate to integrate the TrueSpike™ technology into viral clearance services provided by Charles River.
|
20120227 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
01-mar-2012 |
The increased efficiency offered by CellPrime recombinant human lysozyme, combined with high activity levels, results in a reduction of overall production costs.
|
20120301 |
Produzione biofarmaceutica |
|
12-mar-2012 |
This joint project will focus on the development of a proprietary monitoring and control methodology, enabling robust growth of adherent human pluripotent stem cells.
|
20120312 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
07-ago-2012 |
CellPrime™ Insulin stimulates the proliferation of cells and aids in carbohydrate metabolism, helping to ensure the long-term viability of various cell lines.
|
20120807 |
Produzione biofarmaceutica |
|
20-giu-2012 |
Provantage Solutions provide greater control and increased flexibility for both small and large molecule development and manufacturing processes.
|
20120620 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
10-apr-2012 |
Presentations and discussions will explore the recent launch of the new excipients certification program EXCiPACT™.
|
20120410 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
10-lug-2012 |
This unique fully-embedded water purification system software has been developed especially for the pharmaceutical, biotech and contract labs that follow GxP regulations.
|
20120710 |
|
|
20-set-2012 |
The site will serve users of Merck Millipore’s Provantage™ Biodevelopment and Clinical Supply Solutions option that incorporates the latest technologies for upstream and downstream processes.
|
20120920 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
12-set-2012 |
“We are very proud to make the Boston Business Journal’s List of Top Charitable Contributors once again,” says Tara Duplaga, Manager of the Merck Millipore Giving Program.
|
20120912 |
|
|
30-ago-2012 |
World Water Week, held this year from August 26 to September 1, provides a forum for conversation and best practices concerning the ongoing clean water crisis in our global community.
|
20120830 |
|
|
08-ago-2012 |
This novel design protects product integrity and prevents product loss during sample collection, transport and especially during long term storage where stress release can induce leakage.
|
20120808 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
06-ago-2012 |
The Mobius FlexReady Solution with Smart Flexware Assemblies for Chromatography is a fully-automated system designed to achieve optimum performance.
|
20120806 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
22-ago-2012 |
The acquisition will strengthen Merck Millipore’s Process Solutions business unit, which provides products, services and solutions that simplify production complexity for manufacturers.
|
20120822 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
14-ago-2012 |
PureGenome library preparation is a simple, two-step process followed by amplification using Merck Millipore’s ultra-high fidelity KOD Hot Start DNA Polymerase Mastermix.
|
20120814 |
Reagenti, prodotti chimici e attrezzature per il laboratorio,
Ricerche life science
|
|
05-lug-2012 |
The Samplicity® Filtration system provides a higher throughput, ergonomic alternative to syringe-tip filters for the preparation of liquid chromatography samples.
|
20120705 |
Analisi e preparazione dei campioni,
Ricerche life science
|
|
14-mag-2012 |
Red dot is one of the world’s largest and most prestigious design competitions from Germany, and is one of the most sought-after quality marks for design recognition globally.
|
20120514 |
Ricerche life science
|
|
17-apr-2012 |
The synthetic membrane can be successfully used in place of human or animal skin to provide information about permeation characteristics of the compound through human skin.
|
20120417 |
Ricerche life science
|
|
16-apr-2012 |
The goal of Merck Millipore’s rebrand initiative was to support strategic branding during the merger and to define the brand’s positioning, vision, and mission.
|
20120416 |
|
|
21-mar-2012 |
This product, which utilizes Ventria’s ExpressTec biomanufacturing technology, will be exclusively marketed and distributed by Merck Millipore to its customers on a global basis.
|
20120321 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
19-set-2012 |
This project will focus on the development required to ensure removal of microcarriers and any particulates from stem cell products grown in the Mobius® CellReady disposable bioreactor.
|
20120919 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
18-ott-2012 |
The price adjustments are being driven by recent and anticipated cost increases, macroeconomic trends and inflation among other considerations.
|
20121018 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
09-ott-2012 |
This includes products for all types of dosage forms that address solubility, PK/PD modification, which must be taken into account for optimized bioavailability in the final drug.
|
20121009 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
12-ott-2012 |
The fund will be in the form of two grants of $250,000 each over a two-year period, and is the latest development in Merck Millipore’s two-year alliance with BCRF.
|
20121012 |
|
|
05-set-2012 |
The new media formulation was designed for the long-term growth of Chinese Hamster Ovary (CHO) cells to express antibodies or protein products.
|
20120905 |
Produzione biofarmaceutica |
|
18-set-2012 |
Large-scale production of stem cells is necessary to enable their advancement into human clinical trials and to effectively deliver the quantities required.
|
20120918 |
Piccole molecole di interesse farmaceutico,
Ricerche life science
,Produzione biofarmaceutica |
|
17-set-2012 |
Under the agreement, Merck Millipore will continue to offer its STEMCCA™ reprogramming kits, which provide a highly efficient, reproducible method for creating iPS cells.
|
20120917 |
Ricerche life science
|
|
07-gen-2013 |
Unlike traditional single-use processing systems, this modular system is quick and easy to set up, providing the ability to switch from TFF to Chromatography.
|
20130107 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
15-nov-2012 |
Built on Merck Millipore’s proven Eshmuno resin technology, the new media offers high aggregate removal efficiency and high dynamic binding capacity, supporting highly productive downstream bioprocessing.
|
20121115 |
Produzione biofarmaceutica |
|
13-nov-2012 |
User Group Meetings attract global biotechnology and biopharmaceutical industry professionals, including those in chromatography R&D, process development, production management and engineering.
|
20121113 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
01-nov-2012 |
The two companies are jointly developing a methodology utilizing Sistemic’s microRNA marker detection capability to enable consistent growth of stem cells.
|
20121101 |
Piccole molecole di interesse farmaceutico,
Ricerche life science
,Produzione biofarmaceutica |
|
30-apr-2013 |
Mineralization can be detected in less than one week, whereas competing products that contain serum require approximately 21 days to produce similar levels of bone formation.
|
20130430 |
Ricerche life science
|
|
23-apr-2013 |
Unlike conventional assays that are dependent upon a single pre-labeled fluorescently tagged substrate, the SIRTainty Class III HDAC Assay employs untagged acetylated peptide substrates.
|
20130423 |
Ricerche life science
|
|
28-feb-2013 |
The Chicago Athenaeum: Museum of Architecture and Design and Metropolitan Arts Press Ltd. present the Museum's annual GOOD DESIGN® Awards Program.
|
20130228 |
Ricerche life science
|
|
02-mag-2013 |
Merck Millipore announced the settlement of patent infringement disputes between Merck Millipore and W.L. Gore & Associates, Inc. in the U.S. District Court for the District of Massachusetts.
|
20130502 |
Piccole molecole di interesse farmaceutico,Produzione biofarmaceutica |
|
29-gen-2013 |
The EZ-product family now includes the EZ-Fluo™ rapid detection system, a non-destructive, fluorescent staining-based system for microbial detection.
|
20130129 |
Microbiologia industriale |
|
14-mag-2013 |
These new kits enable target chromatin enrichment from both low and high amounts of input chromatin while delivering low backgrounds, high signal-to-noise ratios.
|
20130514 |
Ricerche life science
|
|
31-mar-2012 |
A system for rapid, simplified protein quantitation exploits Merck Millipore’s membrane expertise to enable infrared-based measurement of amide bonds in protein chains.
|
20120331 |
Ricerche life science
|
